Soleno Therapeutics have released the results of the Randomised Withdrawal Trial stage of their DCCR clinical programme. These findings, now published in the Journal of Clinical Endocrinology and… Read More »VYKAT XR/DCCR Withdrawal Trial Results Published 

The Biggest Year Yet for FPWR UK and PWS Research As we close the chapter on 2025, I find myself reflecting on what an extraordinary… Read More »2025 – a message from our Chairperson

Rhythm Pharmaceuticals has shared early results from a Phase 2 study of a drug called setmelanotide in people with Prader-Willi syndrome (PWS). This is an exciting development because it… Read More »Rhythm Pharmaceuticals announce promising early data on their trial of Setmelanotide 

For families living with Prader-Willi syndrome (PWS), the relentless drive to eat is a well-known and daily struggle. A key area of PWS research is… Read More »Boosting Brain Signals to Help Regulate Appetite in PWS 

A personal perspective from Professor Tony Holland We are deeply grateful to Professor Tony Holland for sharing his reflections on over 30 years of research… Read More »30+ years of research into PWS

Following our visit to the University of Cambridge last week, we have been asked to share details of an exciting new study. A research team… Read More »Mitochondria Research Opportunity